Christopher Morabito Astria Therapeutics, Inc. (ATXS) insider trading activity

Christopher Morabito is Chief Medical Officer of Astria Therapeutics, Inc.. Currently has a direct ownership of 0 shares of ATXS, which is worth approximately $0. The most recent transaction as insider was on Apr 01, 2024, when has been sold 10,000 shares (Common Stock) at a price of $13.59 per share, resulting in proceeds of $135,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

n/a 12M change

Total Value Held $0

Christopher Morabito Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2024	SELL Open market or private sale	$135,900 $13.59 p/Share	10,000 Reduced 100.0%	0 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$38,700 $3.87 p/Share	10,000 Added 50.0%	10,000 Common Stock
Jan 29 2024	SELL Open market or private sale	$102,580 $11.15 p/Share	9,200 Reduced 100.0%	0 Common Stock
Jan 29 2024	BUY Exercise of conversion of derivative security	$35,604 $3.87 p/Share	9,200 Added 50.0%	9,200 Common Stock
Jan 26 2024	SELL Open market or private sale	$8,816 $11.02 p/Share	800 Reduced 100.0%	0 Common Stock
Jan 26 2024	BUY Exercise of conversion of derivative security	$3,096 $3.87 p/Share	800 Added 50.0%	800 Common Stock

Also insider at

FULC

Fulcrum Therapeutics, Inc. Healthcare

Chief Medical Officer